GPLB 10-K & 10-Q changes, risk factors and insider trading
Green Planet Bio Engineering Co. Ltd. · OTC · Biological Products, (No Diagnostic Substances) · CIK 1392449 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
No wording changes found in this section (only numbers or dates changed in 3 paragraphs).
Full comparison: every changed paragraph (0)
What changed in the latest 10-Q
Risk Factors
The Company’s critical accounting policies are still being applied despite the fact that Company has no ongoing business operations.
Significant Estimates
We prepare our financial statements in conformity with generally accepted accounting principles in the United States of America. As such, we are required to make estimates, judgments and assumptions that we believe are reasonable based upon historical experience, current trends and other factors. These estimates, judgments and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could be different than those estimates.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.
Market Risks
There has been no material change in market risks since our last Annual Report on Form 10-K for the year ended December 31, 2025.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
Results of Operations and Financial Condition for thesee in full comparisonthreesix months endedMarchJune31,30, 2026, as compared to thethreesix months endedMarchJune31,30, 2025.
Full comparison: every changed paragraph (3)
Results of Operations and Financial Condition for the threesix months ended MarchJune 31,30, 2026, as compared to the threesix months ended MarchJune 31,30, 2025.
The Company had no active business operations for the periods ended MarchJune 31,30, 2026 and MarchJune 31,30, 2025. Expenses consist of accounting and filing fees.
The Company had no active business operations for the threesix months ended MarchJune 31,30, 2026. Accordingly, all of the Company’s cash flow needs were provided by a related party of Global Funds, the majority stockholder to pay expenses necessary as a public company.
GPLB insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding GPLB (13F)
None of the 59 investors we track reported a position in their latest 13F.